# The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament

> **NCT06207253** · PHASE2,PHASE3 · RECRUITING · sponsor: **British University In Egypt** · enrollment: 48 (estimated)

## Conditions studied

- Endodontic Disease
- Pulp Disease, Dental
- Intracanal Medication

## Interventions

- **DRUG:** Diclofenac Sodium
- **DRUG:** Calcium hydroxide

## Key facts

- **NCT ID:** NCT06207253
- **Lead sponsor:** British University In Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06207253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06207253, "The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06207253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*